Resources
12 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 1/5/2021 (updated 4/4/2024)
Bringing Recovery Supports to Scale Technical Assistance Center Strategy (BRSS TACS) created this directory based on information obtained from state certification boards for alcohol and substance use professionals, state mental health and substance use disorder authorities, sources identified by the International Certification & Reciprocity Consortium (IC&RC), local and statewide recovery community organizations, and the National Association of State Alcohol and Drug Abuse Directors. The information sources for each state are noted. All italicized text is a direct quote from the source noted. The information in this directory was current as of June 24, 2020.
Posted 10/5/2021 (updated 4/3/2024)
This webinar focused on the crucial role of the emergency department (ED) in recognizing and treating opioid use disorder (OUD) patients with evidence-based medications for addiction treatment. Gail D’Onofrio, MD, discussed her pioneering work in creating the evidence for initiating ED buprenorphine treatment with ED patients presenting with opioid use disorder. Overall, the opioid epidemic intertwined with the COVID-19 pandemic has greatly escalated the need to mitigate the morbidity and mortality associated with the rising rate of fentanyl use. Data supporting the use of buprenorphine in the ED setting as well as the consequences of not initiating treatment will be discussed. While the use of ED prescribed buprenorphine has increased, universal adoption has lagged. Barriers to implementation of ED buprenorphine were discussed as well as strategies to overcome these challenges. Components of successful integration of an ED program with community partnerships was outlined. Current research by emergency physicians regarding innovative strategies such as high-dose buprenorphine inductions and use of extended release 7-day formulation of buprenorphine will be discussed. Initiation buprenorphine effectively, reduces withdrawal symptoms, improves adherence to treatment, and saves lives.
Posted 12/9/2020 (updated 4/3/2024)
Emergency Department initiated buprenorphine. This guide includes an overview, list of protocols, tools, and assessments for providers.
Posted 6/26/2020 (updated 3/28/2024)
This brief, made possible by the Centers for Medicare & Medicaid Services, highlights key features of approved health home models in Maryland, Rhode Island, and Vermont that are tailored to individuals with opioid dependency.
Posted 6/16/2020 (updated 3/28/2024)
The most effective therapy for people with opioid use disorder involves the use of Food and Drug Administration-approved medications—methadone, buprenorphine, and naltrexone. Despite evidence that this approach, known as medications for opioid use disorder, reduces relapse and saves lives, the vast majority of jails and prisons do not offer this treatment.
Posted 4/29/2020 (updated 3/28/2024)
Generations United's National Center on Grandfamilies works to enact policies and promote programs to help grandfamilies address challenges.
Posted 6/18/2023 (updated 3/28/2024)
The North Carolina Emergency Department (ED) Peer Support Program enables participating North Carolina hospitals to embed certified peer support specialists in their emergency departments to connect patients presenting with opioid overdose to treatment, recovery, resources and harm reduction supports. This guide is a tool for introducing an ED peer support program in a hospital setting.
Posted 2/28/2023 (updated 3/27/2024)
Researchers looked at records for 917 patients who engaged with a peer recovery coach via telehealth after discharge from emergency departments for opioid use. The investigation focused on one Indiana-based hospital system that included six hospitals located in cities and seven that had rural Critical Access Hospital designations.
Posted 6/8/2023 (updated 3/27/2024)
Buprenorphine is a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder (OUD) with a relatively low rate of triggering precipitated withdrawal in patients. Increased precipitated withdrawal rates have become a concern for practitioners in emergency departments when treating with buprenorphine with the prevalence of fentanyl in the drug supply.
Posted 4/14/2023 (updated 3/27/2024)
Researchers evaluate The Kentucky Access to Recovery Program (KATR), which provides services to individuals recovering from opioid use in several counties in Eastern Kentucky, and conclude KATR demonstrates a potentially effective strategy for increasing health-related social services in rural areas.